Ulf Nehrbass
Directeur Général chez Luxembourg Institute of Health
Profil
Ulf Nehrbass is currently the Chief Executive Officer at Luxembourg Institute of Health.
Previously, he held the same position at Qurient Co., Ltd.
Postes actifs de Ulf Nehrbass
| Sociétés | Poste | Début |
|---|---|---|
Luxembourg Institute of Health
 Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Directeur Général | - |
Anciens postes connus de Ulf Nehrbass
| Sociétés | Poste | Fin |
|---|---|---|
| QURIENT CO., LTD. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QURIENT CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Commercial Services |
